Free Trial

Indivior (INDV) Competitors

Indivior logo
GBX 1,130 +10.00 (+0.89%)
As of 07/3/2025 12:38 PM Eastern

INDV vs. ITH, SOPH, HCM, GRI, SLS, ERGO, SLN, AMYT, BMY, and OGN

Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

Indivior vs. Its Competitors

Ithaca Energy (LON:ITH) and Indivior (LON:INDV) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

Ithaca Energy has higher revenue and earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Ithaca Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ithaca Energy£3.55B0.90£230.29M£8.7617.56
Indivior£1.40B1.26-£2.36M-£1.21-936.93

In the previous week, Indivior had 7 more articles in the media than Ithaca Energy. MarketBeat recorded 7 mentions for Indivior and 0 mentions for Ithaca Energy. Indivior's average media sentiment score of 0.30 beat Ithaca Energy's score of 0.00 indicating that Indivior is being referred to more favorably in the news media.

Company Overall Sentiment
Ithaca Energy Neutral
Indivior Neutral

3.7% of Ithaca Energy shares are owned by institutional investors. Comparatively, 86.0% of Indivior shares are owned by institutional investors. 89.6% of Ithaca Energy shares are owned by insiders. Comparatively, 3.4% of Indivior shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Ithaca Energy pays an annual dividend of GBX 28 per share and has a dividend yield of 18.2%. Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.3%. Ithaca Energy pays out 319.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Indivior pays out -1,243.7% of its earnings in the form of a dividend.

Ithaca Energy has a net margin of 6.48% compared to Indivior's net margin of -0.17%. Ithaca Energy's return on equity of 4.55% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Ithaca Energy6.48% 4.55% 0.18%
Indivior -0.17%-0.77%2.37%

Indivior has a consensus target price of GBX 1,650, suggesting a potential upside of 46.02%. Given Indivior's stronger consensus rating and higher probable upside, analysts plainly believe Indivior is more favorable than Ithaca Energy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ithaca Energy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Indivior
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Indivior beats Ithaca Energy on 9 of the 17 factors compared between the two stocks.

Get Indivior News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INDV vs. The Competition

MetricIndiviorDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.77B£2.11B£5.50B£2.96B
Dividend Yield4.48%2.92%5.38%5.02%
P/E Ratio-936.934.1727.60146.59
Price / Sales1.26545.47369.09240,167.53
Price / Cash2.6810.3536.6327.97
Price / Book-8.9411.868.055.30
Net Income-£2.36M£21.15B£3.18B£5.90B
7 Day Performance14.60%2.11%2.82%0.92%
1 Month Performance13.00%4.79%3.70%5.20%
1 Year Performance-4.64%2.83%35.41%80.76%

Indivior Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INDV
Indivior
3.148 of 5 stars
GBX 1,130
+0.9%
GBX 1,650
+46.0%
-2.8%£1.77B£1.40B-936.931,000
ITH
Ithaca Energy
N/AGBX 157
-0.4%
N/A+24.6%£3.27B£3.55B17.93220
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
HCM
HUTCHMED
N/AGBX 221.81
-2.3%
N/A-16.1%£2.41B£771.01M-56.611,760
GRI
Grainger
3.5184 of 5 stars
GBX 221.50
+0.7%
GBX 317.50
+43.3%
-11.9%£1.64B£276.05M-1,476.67372News Coverage
Dividend Increase
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
3.0278 of 5 stars
GBX 504
-1.6%
GBX 825
+63.7%
-24.0%£406.69M£382.40M10.7834,300News Coverage
Gap Up
OGN
Origin Enterprises
N/AGBX 3.68
flat
N/A+14.2%£388.03M£183.08B10.6310,000Dividend Increase

Related Companies and Tools


This page (LON:INDV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners